Skip to search formSkip to main contentSkip to account menu

P276-00

Known as: CDK Inhibitor P276-00 
A flavone and cyclin dependent kinase (CDK) inhibitor with potential antineoplastic activity. P276-00 selectively binds to and inhibits Cdk4/cyclin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Background: Breast cancer outcomes from the Women’s Health Initiative (WHI) Estrogen plus Progestin and Estrogen-alone trials… 
2014
2014
In this paper we present a tabu search-based algorithm, which is dedicated to solving the routing and spectrum allocation problem… 
2012
2012
Creating useful software is a major activity of many scientists, including bioinformaticians. Nevertheless, software development… 
2012
2012
P276-00 is a novel cyclin-dependent kinase inhibitor currently in Phase II clinical trials. Gemcitabine is a standard of care for… 
2008
2008
Purpose: This instruction contains policies and procedures for inspecting workplaces that create or handle combustible dusts. In… 
Highly Cited
2007
Highly Cited
2007
P276-00, a flavone that inhibits cyclin-dependent kinases, has been identified by us recently as a novel antineoplastic agent. In… 
2005
2005
With the aim of characterizing the agronomical behaviour, yield components and its correlation to the yield in genotypes of the… 
2004
2004
Objective: This study was designed to estimate the prevalence of and evaluate risk factors for subclinical vitamin A deficiency… 
2001
2001
Self-timed scheduling is an attractive implementation style for multiprocessor DSP systems due to its ability to exploit…